FDA slashes number of analytical tests for IVDs used in public health emergencies

The US Food and Drug Administration (FDA) on Monday finalized guidance to assist manufacturers in validating in vitro diagnostic devices (IVDs) that test for emerging pathogens during public health emergencies. The guidance also provides recommendations on how this validation data should be submitted in a pre-Emergency Use Authorization (EUA) or an EUA request.